Vitamin D₃ Supplementation in Batswana Children and Adults with HIV: A Pilot Double Blind Randomized Controlled Trial by Andrew P. Steenhoff (199381)

“…HAZ and CD4% increased and VL decreased in the 7000IU/d group (p<0.04). Younger (5–13y) and older (30–50y) subjects had greater Δ25D than those 14–29y (26±17 and 28±12 vs. 11±11ng/ml, respectively, p≤0.001). …”

V3-loop changes in Env_HXB2 do not alter the irreversibility of anti-MPER NAb 10E8v4 neutralization. by Hannah M. Schapiro (12563123)

“…A portion of these samples (± antibody) was diluted 10-fold either immediately or after a 1-hour incubation at 37°C. …”

DataSheet_1_Vitamin D Supplementation Improves Handgrip Strength in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.doc by Jia-Li Zhang (112180)

hMSCs inhibit TNF-α secretion from macrophage-like cells more efficiently in the presence of IFN-γ. by Mika Pietilä (332438)

EDA2 down-regulates activated EGFR and reduces cell viability. by Laura E. Hanold (705810)

Knockdown of BMPRII did not affect BMP4 elevated basal [Ca²⁺]_i and SOCE in PASMCs. by Yi Zhang (9093)

“…<p>(A) bar graph showing the changes in basal [Ca²⁺]_i in distal PASMCs treated with 50 ng/ml BMP4 (n  =  4 from 120 cells) for 60 h. …”

<i>S</i>. <i>pneumoniae</i> RNA regulators are ligand responsive and most designed mutations function as anticipated. by Indu Warrier (581139)

“…Bar height indicates the mean replicate value, error bars indicate standard error of the mean, individual points shown in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011188#pgen.1011188.s009" target="_blank">S2 Fig</a>. …”

CtBP1 and c-Myc upregulate β-catenin and are markers of tumor progression in colorectal carcinomas. by Taranjit S. Gujral (250748)

“…The immunoreactivity of CtBP1 was classified using a four-grade scale: 0, fewer than 10% positively stained cells; 1, between 10% and 25%; 2, between 25% and 50%; and 3, greater than 50%. …”

Optimisation of read depth, DNA quantity, and unique alternate observation threshold. by Melinda L. Tursky (20790436)

“…D-F: Blood samples from 383 community-dwelling subjects were sequenced at a target depth of 3,000-4,000 × . Variants with a prevalence of ≥ 10% within this cohort were excluded as likely sequencing artefacts, which excluded 10.5% of variants (D). …”